![David Moore](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Moore
Directeur/Membre du Conseil chez
CORIUM INTERNATIONAL INC
Fortune : 304 668 $ au 31/08/2026
Profil
Mr. David S.
Moore is a Senior Partner at ARCH Venture Partners LLC, an Independent Director at Corvus Pharmaceuticals, Inc. and a Chairman at Novasenta, Inc. He is on the Board of Directors at Corvus Pharmaceuticals, Inc., Corium LLC (Massachusetts) and Tremeau Pharmaceuticals, Inc. Mr. Moore was previously employed as a Partner by Gurnet Point Capital LLC, a Chief Executive Officer by Roivant Sciences, Inc., a Senior Vice President-US Commercial by Novo Nordisk, Inc., a President & Chief Commercial Officer by Cempra, Inc., an Independent Director by Sirona Biochem Corp., a Chief Business Officer by OCERA Therapeutics LLC, and a Chief Business Officer by Tranzyme Pharma, Inc. (Canada).
He also served on the board at Alladapt Immunotherapeutics, Inc. He received his undergraduate degree from Thomas Jefferson University, an undergraduate degree from Towson University and an MBA from Lehigh University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/06/2026 | 21 700 ( 0,03 % ) | 304 668 $ | 31/08/2026 |
Postes actifs de David Moore
| Sociétés | Poste | Début |
|---|---|---|
| CORIUM INTERNATIONAL INC | Directeur/Membre du Conseil | - |
| CORVUS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 02/10/2025 |
Tremeau Pharmaceuticals, Inc.
 Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers non-opioid pain therapies for people | Directeur/Membre du Conseil | - |
Novasenta, Inc.
 Novasenta, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for immune-mediated diseases and cancer | Président | 01/01/2023 |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Private Equity Investor | 01/04/2026 |
Anciens postes connus de David Moore
| Sociétés | Poste | Fin |
|---|---|---|
Gurnet Point Capital LLC
 Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and medical technologies sector. It provides financing for buyout stage capital requirements. It also acquires majority stake and control positions. | Private Equity Investor | 30/09/2022 |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Directeur Général | 01/03/2020 |
Cempra, Inc.
 Cempra, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company with interest in manufacturing pharmaceutical products | President | 01/05/2019 |
| SIRONA BIOCHEM CORP. | Directeur/Membre du Conseil | 27/10/2017 |
| ░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de David Moore
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
62
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Thomas Jefferson University
 Thomas Jefferson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
Sirona Biochem Corp.
 Sirona Biochem Corp. Pharmaceuticals: MajorHealth Technology Develops cosmetic and pharmaceutical active ingredients | Health Technology |
Cempra, Inc.
Cempra, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company with interest in manufacturing pharmaceutical products | Health Technology |
Corvus Pharmaceuticals, Inc.
 Corvus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides anticancer immuno-oncology drugs | Health Technology |
OCERA Therapeutics LLC
 OCERA Therapeutics LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Lehigh University
 Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Towson University
 Towson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corium International, Inc.
 Corium International, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of novel neuroscience therapies | Health Technology |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Health Technology |
Tranzyme Pharma, Inc. (Canada) | |
Gurnet Point Capital LLC
Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and medical technologies sector. It provides financing for buyout stage capital requirements. It also acquires majority stake and control positions. | Finance |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Tremeau Pharmaceuticals, Inc.
Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers non-opioid pain therapies for people | Health Technology |
Alladapt Immunotherapeutics, Inc.
 Alladapt Immunotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics targeting food allergy | Health Technology |
Novasenta, Inc.
Novasenta, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for immune-mediated diseases and cancer | Health Technology |
